CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Open-market sale Chief Executive Officer sold 146,388 shares at an average $51.91 ($7,598,864)
- 4 Option exercise Chief Executive Officer acquired 11,806 shares (option exercise)
- 4 Open-market sale General Counsel sold 32,500 shares at an average $61.72 ($2,005,875)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Grant or award Director acquired 6,400 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 40,000 shares at an average $61.70 ($2,467,941)
- 4 Open-market sale Senior Vice President sold 25,625 shares at an average $64.57 ($1,654,591)
- 4 Open-market sale Director sold 4,500 shares at an average $64.72 ($291,244)
- 4 Open-market sale Director sold 4,050 shares at an average $64.75 ($262,233)
- 4 Open-market sale Director sold 4,500 shares at an average $64.71 ($291,177)
- 4 Open-market sale Director sold 4,500 shares at an average $64.71 ($291,192)
- 4 Grant or award Senior Vice President acquired 55,000 shares (grant or award)
- 4 Option exercise General Counsel acquired 28,000 shares (option exercise)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
- 4 Open-market buy Director bought 655 shares at $66.37 ($43,472)
Page 7 of 25 · 497 filings